Portfolio company
Sequence Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a big data platform for drug discovery by analysing genetic information from a founder population for pharmaceutical and biotechnology partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Fauna Bio
This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners by analysing genetic data from disease-resistant animal species.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Curoverse
This company develops a computing platform for managing and analysing genomic data sets for research institutions, pharmaceutical companies and clinical testing labs.
Geneseque
This company develops a single-molecule DNA sequencing technology for the life sciences sector and research partners.
Generare
This company develops a discovery platform that generates molecular data from microbial genomes for pharmaceutical and crop protection companies to advance drug and product development.
DNA1
This company develops a platform for relating phenotype to genotype to accelerate discoveries in diagnostics, precision medicine, and genetics for healthcare organisations.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
